White label ELPA - ClinicalTrials.eu

Study of Amoxicillin-clavulanic acid, Piperacillin-tazobactam and Meropenem dosing in critically ill children with systemic infections

Recruiting

3 1 1 1
Investigated Diseases:
- Critical illness
Investigated Drugs:
Study on Adding Atezolizumab and WT1/DC Vaccine to Standard Treatment for Patients with Epithelioid Malignant Pleural Mesothelioma

Recruiting

2 1 1 1
Investigated Diseases:
- Pleural mesothelioma malignant
Investigated Drugs:
- Wt1 Lamp Mrna Dc
- Atezolizumab
Comparison of Short vs Long-term Hormone Therapy with Goserelin, Leuprorelin, or Triptorelin Combined with Radiation for Prostate Cancer Patients After Surgery

Recruiting

3 1 1 1
Investigated Diseases:
- Prostate cancer
Investigated Drugs:
Study on Botulinum Toxin Type A and Sodium Chloride for Patients with Treatment-Resistant Chronic Cluster Headache

Recruiting

3 1 1
Investigated Diseases:
- Cluster headache
Investigated Drugs:
- Botulinum Toxin Type A
- Sodium Chloride
Study of Chemotherapy with or without FUDR/Dexamethasone for Patients with Inoperable Liver Bile Duct Cancer

Recruiting

2 1 1
Investigated Diseases:
- Cholangiocarcinoma
Investigated Drugs:
- Floxuridine
Study on Olaparib and Bevacizumab for Patients with Advanced Ovarian, Fallopian Tube, or Peritoneal Cancer

Recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Olaparib
- Bevacizumab
Comparison of ruxolitinib versus hydroxycarbamide or interferon alfa as first treatment for high-risk polycythemia vera patients

Recruiting

3 1 1 1
Investigated Drugs:
Study on Alzheimer’s Disease Using Flortaucipir (18F) for Early Diagnosis in At-Risk Patients

Recruiting

2 1 1
Investigated Diseases:
- Dementia Alzheimer’s type
Investigated Drugs:
- Flortaucipir (18F)
Study on Ponatinib and Imatinib for Adults with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia

Recruiting

2 1 1 1
Investigated Diseases:
- Acute lymphocytic leukaemia
Investigated Drugs:
Study of ART27.13 for Patients with Cancer-Related Anorexia and Weight Loss

Recruiting

2 1
Investigated Diseases:
- Decreased appetite
Investigated Drugs:
- N-{2-Tert-Butyl-1-[(4,4-Difluorocyclohexyl)Methyl]-1H-1,3-Benzodiazol-5-Yl}Ethane-1-Sulfonamide
- Placebo

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies